Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease that affects somewhere between 4 and 40 people per million worldwide. The condition causes substances such as fats and proteins ...

Relative alveolar hypoventilation is directly related to the compensatory mechanisms that follow pulmonary vascular occlusion. Because of the mechanical block in the circulation, blood is diverted ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team of Columbia and UCSD researchers may have found a clever solution that ...

Savara is on track for potential approval by the end of 2025 for MOLBREEVI™s in autoimmune pulmonary alveolar proteinosis (aPAP), assuming the treatment receives priority review. The company has ...

But why does pulmonary fibrosis in post-COVID-19 tend to resolve while it progresses in people with IPF who aren’t sick from COVID-19? “Both diseases are caused by injury to alveolar epithelia ...